Prof. Dr. Matthias Emanuel Liechti
Forschungsgruppenleiter
Lehrbeauftragter
Lehrbeauftragter

Matthias Emanuel Liechti

Medizinische Fakultät

FG Liechti

Forschungsgruppenleiter

Departement Biomedizin
Hebelstrasse 20
4031 Basel
Schweiz

Tel. +41 61 328 68 68
matthias.liechti@unibas.ch


Medizinische Fakultät

Klinische Pharmakologie

Lehrbeauftragter

Universitätsspital Basel
Petersgraben 4
4031 Basel
Schweiz

Tel. +41 61 328 68 68
matthias.liechti@unibas.ch


Philosophisch-Naturwissenschaftliche Fakultät

Departement Pharmazeutische Wissenschaften

Lehrbeauftragter

Departement Pharmazeutische Wissenschaften
Klingelbergstrasse 50
4056 Basel
Schweiz

Tel. +41 61 328 68 68
matthias.liechti@unibas.ch

Curriculum Vitae

Matthias Liechti graduated form the Medical School, University of Zurich Switzerland in 1998. He was a postdoc at the Universits Hospital of Psychiatry Zurich in 1999-2000 where he studied the pharmacology of psychoactive drugs. He then trained in internal medicine at the University Hospital of Zurich and obtained his spezialization in internal medicine in 2004. From 2005–2007 he was a postdoctoral researcher at the Scripps Research Institute, La Jolla and at the University of California, San Diego (UCSD) and trained in behavioral pharmacology. In 2007 he also completed a Master in Advanced Studies in Clinical Research at UCSD. Since 2008 he works at the Division of Clinical Pharmacology at the University Hospital of Basel. Matthias Liechti is an attending physician at the hospital and head of the psychopharmacology research group at the Department of Biomedicine of the University Hospital. His scientific interest are mechanism of action of psychoactive drugs, psychostimulants, addiction, CNS drug development and translational research methodologies. Direct links to research: Pharmaceutical Sciences, Biomedicine and Universitaetsspital Basel.

Strajhar, P., Vizeli, P., Patt, M., Dolder, P. C., Kratschmar, D. V., Liechti, M. E. und Odermatt, A. (2019) «Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study», Journal of Steroid Biochemistry and Molecular Biology. Elsevier, 186, S. 212-225. doi: 10.1016/j.jsbmb.2018.10.016.   edoc
Mayer, F. P., Cintulova, D., Pittrich, D. A., Wimmer, L., Luethi, D., Holy, M., Jaentsch, K., Tischberger, S., Gmeiner, G., Hoener, M. C., Liechti, M. E., Mihovilovic, M. D. und Sitte, H. H. (2019) «Stereochemistry of phase-1 metabolites of mephedrone determines their effectiveness as releasers at the serotonin transporter», Neuropharmacology. Elsevier, 148, S. 199-209. doi: 10.1016/j.neuropharm.2018.12.032.   edoc
Müller, F., Brändle, R., Liechti, M. E. und Borgwardt, S. (2019) «Neuroimaging of chronic MDMA (‹ecstasy›) effects: A meta-analysis», Neuroscience and biobehavioral reviews. Elsevier, 96, S. 10-20. doi: 10.1016/j.neubiorev.2018.11.004.   edoc | Open Access